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are transported through the bacterial cell envelope via the hollow 
rod and needle proteins, and injected through the translocation pore 
into the host cell. Assembly of the injectisome is dependent upon 
the T3SS which is located in the inner membrane and is thought to 
occur in a highly ordered process involving sequential secretion and 
assembly of the rod, needle, and translocator proteins (Wagner et al., 
2010). While the injectisome structure and composition is highly 
conserved, each pathogen has a unique set of effector proteins suited 
to its individual lifestyle (Coburn et al., 2007). P. aeruginosa uses 
the injectisome to translocate at least five effector proteins (ExoS, 
ExoT, ExoU, ExoY, and FliC) into host cells (Hauser, 2009). The 
translocated effectors facilitate phagocytic avoidance, tissue inva-
sion and systemic spread, and modulate the inflammatory response 
(Engel and Balachandran, 2009). Regulation of T3SS transcription is 
intrinsically controlled by the activity of the injectisome through a 
well-described and self-  contained (encoded) regulatory mechanism 
(Brutinel and Yahr, 2008). T3SS gene expression is also influenced by 
extrinsic regulatory genes but in most cases the mechanisms involved 
are poorly understood. In this review we focus on recent progress 
toward defining mechanisms that regulate T3SS gene expression.
INTRINSIC REGULATION OF T3SS GENE EXPRESSION
ExsA IS ThE CENTRAL REGULATOR OF T3SS GENE EXPRESSION
The P. aeruginosa T3SS regulon consists of ∼40 genes organized 
within 10 transcriptional units that encode the secretion and trans-
location machinery, intrinsic regulators of T3SS gene expression 
INTRODUCTION
Pseudomonas aeruginosa is widely appreciated for its ability to 
survive under adverse conditions. In its native habitat of soil and 
water, P. aeruginosa is exposed to a myriad of potential growth 
substrates, competing microorganisms, and outright predators. 
To cope with these hostile conditions P. aeruginosa has a relatively 
large genome (6.3 Mb) encoding diverse metabolic pathways and 
defense mechanisms, and has extensive regulatory networks that 
reprogram gene expression patterns to suit the prevailing envi-
ronmental conditions (Stover et al., 2000). Many of the defense 
mechanisms that provide a selective advantage in soil and water 
also contribute to virulence in the mammalian host. For instance, 
the P. aeruginosa type III secretion system (T3SS) contributes to 
virulence in ameba, insect, zebrafish, and mammalian infection 
models and protects P.   aeruginosa from phagocytosis irrespective 
of whether the phagocyte is an ameba or a human macrophage 
(Pukatzki et al., 2002; Miyata et al., 2003; Brannon et al., 2009).
Type III secretion systems contribute to the virulence of many 
medically relevant Gram-negative organisms and function like a 
molecular syringe to inject bacterial effector proteins into eukaryo-
tic host cells (Coburn et al., 2007). The injectisome consists of ∼25 
proteins that form two ring-like structures embedded in the inner 
and outer membranes, a rod-like structure that spans the periplasmic 
space, a needle-like structure that extends from the cell surface, and 
a translocation complex that forms a channel in the host cell mem-
brane (Moraes et al., 2008; Worrall et al., 2011). The effector proteins 
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doi: 10.3389/fmicb.2011.00089(ExsA, ExsD, ExsC, and ExsE), chaperones, and effectors (Frank, 
1997). The central regulator of the T3SS regulon is ExsA, a mem-
ber of the AraC/XylS family of transcriptional activators (Yahr 
and Frank, 1994; Hovey and Frank, 1995; Yahr et al., 1995). ExsA 
autoregulates its own expression through the PexsC promoter and 
is encoded as the last gene of the exsCEBA polycistronic mRNA 
(Yahr and Frank, 1994). An alignment of the 10 ExsA-dependent 
promoters has identified a consensus binding site (tAaAAAnwnMy-
GrCynnnmYTGayAk) with three areas of high sequence conserva-
tion: an adenine-rich region, a GxC sequence centered at the -45 
position with respect to the transcriptional start site, and a TGxxA 
sequence located near the -35 position (Figure 1; Hovey and Frank, 
1995; Brutinel et al., 2008). Mutagenesis studies have confirmed that 
each of these elements is required for ExsA binding and activation 
of the PexoT promoter (Brutinel et al., 2008).
Typical of most AraC/XylS family members, ExsA has an amino-
terminal domain (NTD) involved in self-association and regula-
tory functions (discussed further below), and a carboxy-terminal 
domain (CTD) that contains two helix-turn-helix DNA-binding 
motifs (Brutinel et al., 2009). In electrophoretic mobility shift assays 
(EMSA) purified ExsA binds to the PexoT, PexsD, and PexsC promoters 
with apparent equilibrium constants in the low (1–5) nM range 
(Brutinel et al., 2008). Two distinct ExsA-promoter complexes are 
observed: a higher mobility complex representing one ExsA mono-
mer bound to the promoter probe and a lower mobility complex 
containing two bound ExsA monomers (Brutinel et al., 2008). 
Mutagenesis and footprinting studies indicate that this binding 
arrangement represents two adjacent binding sites for monomeric 
ExsA with binding site 1 overlapping the conserved GxC and TGxxA 
sequences, and binding site 2 located upstream of site 1 (Figure 1). 
Whereas binding of ExsA to site 1 of the PexoT promoter is required 
for occupation of site 2, deletion of binding site 2 has no effect on 
occupation of site 1 (Brutinel et al., 2008). In addition, occupation 
of binding site 2 is dependent upon monomer–monomer interac-
tions mediated by the amino-terminal domain of ExsA (Brutinel 
et al., 2009). These combined data are supportive of a monomer 
assembly model whereby an ExsA monomer bound to site 1 recruits 
a second ExsA monomer to binding site 2. The apparent lack of 
nucleotide sequence conservation between ExsA binding sites 1 
and 2, however, raises the possibility that monomer–monomer 
FIguRE 1 | Sequence alignment of ExsA-dependent promoters and 
working model for promoter recognition and recruitment of σ70-RNAP by 
ExsA. Nucleotides in bold are highly conserved in all ExsA-dependent promoters 
and have been shown through mutagenesis and DNA-biding studies to be 
important for ExsA-dependent activation. The boxed sequences represent the 
-10 promoter recognition site. Predicted points of interaction for the helix-turn-
helix (HTH) DNA-binding motifs of each ExsA monomer are indicated. Studies 
have shown that ExsA recruits σ70-RNAP through interactions mediated by 
region 4.2 of σ70. The ExsA consensus binding sequence is indicated at the 
bottom of the diagram.
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et al., 2010). ExsC functions as an anti-anti-activator and forms a 2:2 
stoichiometric complex with ExsD (Dasgupta et al., 2004; Lykken 
et al., 2006; Zheng et al., 2007). ExsC is also a T3SS chaperone and 
forms a 2:1 complex with ExsE (Zheng et al., 2007). Finally, ExsE is 
a secreted regulator that prevents ExsC from associating with ExsD 
(Rietsch et al., 2005; Urbanowski et al., 2005). The current working 
model is that ExsA-dependent transcription is inactive under non-
permissive conditions (i.e., high Ca2+) because the binding equi-
libria favor formation of the inhibitory ExsD•ExsA and ExsC•ExsE 
complexes. In contrast, inducing conditions trigger secretion and/
or translocation of ExsE (Urbanowski et al., 2007). The resulting 
decrease in the intracellular concentration of ExsE favors forma-
tion of the ExsD•ExsC complex (i.e., partner switching), thereby 
releasing ExsA to activate transcription. An important feature of 
the regulatory cascade is that minor changes in the levels of ExsC, 
ExsE, ExsA, or ExsD (as little as threefold) can have profound effects 
on T3SS gene expression (Dasgupta et al., 2004).
The partner-switching mechanism predicts that the binding 
affinities of ExsE, ExsC, ExsD, and ExsA are, in order of strongest 
affinity, ExsC•ExsE > ExsC•ExsD > ExsD•ExsA. While the binding 
affinity of the ExsD–ExsA complex has not been determined, the 
binding constants (Kd) for the ExsC•ExsE and ExsC•ExsD com-
plexes are 1 and 18 nM, respectively (Zheng et al., 2007). Recent 
analyses of the ExsE•ExsC and ExsD crystal structures provide 
a basis for the differential binding of ExsC to ExsE and ExsD 
(Bernhards et al., 2009; Vogelaar et al., 2010). The ExsE mono-
mer contains two ExsC-binding domains located in the amino-
and carboxy-terminal portions of the protein and each domain 
contains an Arg-X-Val-X-Arg motif and a partially overlapping 
β-motif.  In  the  co-complex  the  unstructured  ExsE  monomer 
wraps around the ExsC homodimer and each Arg-X-Val-X-Arg 
motif interacts with one of the ExsC monomers, thereby account-
ing for the 2:1 binding stoichiometry of the ExsC•ExsE complex. 
Interestingly,  the  amino-terminal  region  of  ExsD  also  has  an 
Arg-X-Val-X-Arg motif, a β-motif, and shares 22.5% sequence 
identity with the amino-terminus of ExsE. Whereas the entire 
ExsE protein (i.e., both Arg-X-Val-X-Arg motifs) is necessary for 
formation of the ExsC•ExsE complex, the ExsD amino-terminal 
region alone is sufficient to bind ExsC. This observation suggests 
that each ExsD monomer binds to one-half of the ExsC dimer 
and this likely accounts for the 2:2 binding stoichiometry of the 
ExsC•ExsD complex. Furthermore, the presence of a common 
ExsC-binding  motif  in  ExsE  and  ExsD  is  consistent  with  the 
observation that binding of ExsE and ExsD to ExsC are mutually 
exclusive (Vogelaar et al., 2010).
ExsD is a dynamic protein capable of forming a homo–trimeric 
complex in solution, a 1:1 stoichiometric complex with ExsA, 
and a 2:2 stoichiometric complex with ExsC (Zheng et al., 2007; 
Bernhards et al., 2009; Thibault et al., 2009). Curiously, the ExsD 
crystal structure revealed that the amino-terminus of ExsD has 
structural similarity to the DNA-binding domain of the KorB 
transcriptional repressor (Bernhards et al., 2009). The predicted 
DNA-binding interface, however, is buried within the trimeric 
structure  suggesting  that  dissociation  of  the  trimer  might  be 
required for ExsD to exhibit DNA-binding activity. This prop-
erty might account for the observation that trimeric ExsD lacks 
  interactions are the primary determinant for occupation of site 2. 
While genetic studies are suggestive of cooperative binding to the 
PexsC, PexoT, and PexsD promoters, the Hill coefficients derived from 
EMSA experiments are supportive of cooperative binding only at 
the PexsC promoter (1.9 ± 0.2; Brutinel et al., 2008). This discrepancy 
may reflect a fundamental difference in the binding of ExsA to 
the PexsC promoter and is supported by the observation that ExsA 
elicits a significant bend (78°) upon binding to the PexsC promoter 
that correlates with increased promoter activity and cooperative 
binding interactions (Brutinel et al., 2008).
ExsA-dependent promoters possess -35 and -10 sequence ele-
ments similar to those of σ70-dependent promoters with one sig-
nificant difference (Brutinel et al., 2008; Figure 1). Unlike canonical 
σ70-dependent promoters where the -35 and -10 elements are sepa-
rated by ∼17 bp, the same regions in ExsA-dependent promoters are 
separated by 21 or 22 bp. In vitro transcription and primer extension 
assays indicate that the promoters are indeed σ70-dependent and 
that the -10 regions are functional recognition determinants for σ70 
(Vakulskas et al., 2009). The apparent -35 elements, however, are 
not required for recognition by σ70 but rather serve as determinants 
for ExsA binding (Vakulskas et al., 2010). ExsA activates transcrip-
tion by compensating for the lack of functional -35 sites primarily 
through recruitment of RNA polymerase-σ70 holoenzyme to the 
promoter but also has a small effect on isomerization to an open 
complex (Vakulskas et al., 2009). Like many AraC/XylS family mem-
bers, ExsA interacts with region 4.2 of σ70 to recruit RNAP-σ70 to 
the promoter (Vakulskas et al., 2010). Somewhat atypical for an 
AraC/XylS family member, however, is that interactions with the 
α-subunit of RNAP are not required for ExsA-dependent activa-
tion. Although occupation of binding sites 1 and 2 on the pro-
moter is required for ExsA-dependent transcription, it is unclear 
whether one or both monomers interact with RNAP-σ70 to facili-
tate recruitment. The proximity of binding site 1 to the expected 
location for a -35 region, and the fact that ExsA compensates for 
the lack of a functional -35 region, is consistent with a model in 
which ExsA bound to site 1 interacts with region 4.2 of σ70 and 
ExsA bound to site 2 stabilizes ExsA bound to site 1 and/or the 
ExsA-RNAP-σ70 complex.
REGULATION OF ExsA ACTIvITy by ThE ExsADCE REGULATORy 
CASCADE
Type  III  secretion  systems  have  been  described  as  contact- 
dependent secretion systems because translocation of the effector 
proteins requires intimate contact between the pathogen and the 
host, and because host cell contact induces T3SS gene expression 
(Hayes et al., 2010). Growth of P. aeruginosa under Ca2+-limiting 
conditions, or in the presence of serum, mimics the host-contact 
signal and is commonly used in the laboratory as a surrogate for the 
host-contact signal (Frank, 1997; Vallis et al., 1999; Kim et al., 2005; 
Urbanowski et al., 2007). Low Ca2+, serum, and host cell contact 
are each thought to convert the injectisome to a secretion-compe-
tent state through a poorly defined mechanism (Vallis et al., 1999; 
McCaw et al., 2002). ExsA activity is intimately coupled to secre-
tion by a partner-switching mechanism involving three additional 
proteins; ExsC, ExsD, and ExsE (Brutinel and Yahr, 2008). Both 
ExsC and ExsD have two potential binding partners. ExsD is an 
anti-activator that inhibits T3SS gene expression by   disrupting both 
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response to inducing signals (both low Ca2+ and host cell contact; 
Hornef et al., 2000; Rietsch et al., 2004; Urbanowski et al., 2007). 
Bistability is a stochastic process generally reflecting noise in the 
expression of a master regulator (Dubnau and Losick, 2006). Since 
minor changes in the expression levels of ExsA, ExsD, ExsC, or ExsE 
have profound effects on T3SS gene expression, bistable expression 
of the T3SS is likely mediated through the ExsADCE regulatory 
cascade. The biological significance of bistability is not entirely 
clear. Bistability might reflect energetic considerations whereby 
only a subpopulation of T3SS-expressing P. aeruginosa are neces-
sary to neutralize phagocytic clearance or elicit T3SS-dependent 
cytotoxicity during later stages of colonization. In this context, cells 
lacking T3SS gene expression could be likened to the social cheat-
ers described in quorum sensing responses (Sandoz et al., 2007). 
Alternatively, bistability may reflect a state of heightened activation 
that allows a fraction of the cells to respond rapidly to predators. 
Finally, there may be a selective advantage for cells that lack T3SS 
gene expression such as avoidance of antibody responses directed 
against the injectisome.
Whereas the ExsADCE system allows for rapid induction of T3SS 
gene expression, there is a notable lag period in down-  regulation 
following exposure to high Ca2+ conditions (as described above) and 
this lag period likely occurs following the loss of host cell contact 
as well. This regulatory feature may provide for a slow taper in 
T3SS gene expression which, during the interim period between 
full induction and the return to basal expression levels, serves as a 
safeguard against subsequent encounters with phagocytes.
EXTRINSIC REGULATION OF T3SS GENE EXPRESSION
The ExsADCE regulatory pathway is central to T3SS gene regula-
tion but does not operate in isolation. As described in a previous 
review (Yahr and Wolfgang, 2006), many extrinsic regulatory path-
ways involving no less than 30 gene products influence T3SS gene 
expression. In nearly every case, the mechanisms by which they 
exert control over T3SS gene expression is poorly understood. One 
of the future challenges facing the field is to account for regulation 
by each of these pathways and identify the signals to which they 
respond. Despite significant knowledge gaps, molecular details are 
beginning to emerge for some of these systems.
GLObAL REGULATION OF T3SS GENE EXPRESSION by vfr
Virulence factor regulator (Vfr) is a cAMP-dependent regulator of 
transcription that was first identified as an activator of extracel-
lular protease and exotoxin A expression (West et al., 1994). Now 
appreciated as a global regulator of virulence gene expression, the 
Vfr regulon consists of ∼200 genes including type IV pili, a type II 
secretion system, quorum sensing, and the T3SS (Wolfgang et al., 
2003). In addition to Vfr, the system consists of two adenylate cycla-
ses (CyaA and CyaB) and a cAMP phosphodiesterase (Figure 2; 
CpdA; Wolfgang et al., 2003; Fuchs et al., 2010). Both high osmo-
larity (NaCl) and low Ca2+ stimulate cAMP production (Wolfgang 
et al., 2003), and cAMP homeostasis is tightly controlled by CpdA 
(Fuchs et al., 2010). Although a Vfr consensus binding sequence has 
been determined (Kanack et al., 2006), the mechanism by which Vfr 
controls T3SS gene expression remains unknown and represents a 
significant milestone for future studies.
DNA-binding   activity (Bernhards et al., 2009). Future studies will 
be required to   determine whether monomeric and/or dimeric ExsD 
has DNA-binding   activity and, if so, whether such activity is of 
biological significance.
Studies  of  the  ExsD•ExsA  interaction  have  relied  upon  co-
expression of the proteins in vivo and subsequent purification as 
an ExsD•ExsA complex. Consistent with the functional role of ExsD 
as an anti-activator, the purified ExsA•ExsD complex lacks DNA-
binding activity (Thibault et al., 2009; Brutinel et al., 2010). ExsA 
dissociated from the ExsD•ExsA complex through ExsC addition, 
however, is able to bind to DNA, indicating that ExsD does not 
irreversibly inactivate ExsA (Brutinel et al., 2010). The initial and 
rapid transcriptional response to inducing signals, therefore, likely 
reflects dissociation of existing ExsD•ExsA complexes by ExsC.
The response to non-inducing signals (i.e., high Ca2+) appears 
more complicated because neither purified trimeric ExsD, nor ExsD 
dissociated from the ExsC•ExsD complex, is capable of binding to 
ExsA in vitro (Thibault et al., 2009; Brutinel et al., 2010). These 
data, when combined with the observation that ExsD•ExsA complex 
formation is dependent upon concurrent expression of the pro-
teins in vivo, suggest that complex formation may involve a folding 
intermediate of either ExsD or ExsA. ExsD dissociated from the 
ExsC•ExsD complex, therefore, does not contribute to the inhibi-
tion of ExsA-dependent transcription. Furthermore, the fact that 
trimeric ExsD is unable to bind to ExsA suggests two potential path-
ways for irreversible inactivation of ExsD: homo–  trimerization and 
ExsC•ExsD complex formation. The response to inhibiting signals 
(i.e., high Ca2+) exhibits a lag period (Diaz and Yahr, unpublished) 
that may reflect a requisite decay of the existing free ExsA and a 
requirement for de novo synthesis of ExsD to sequester the newly 
synthesized ExsA.
ExsD inhibits both the self-association and DNA-binding prop-
erties of ExsA (Thibault et al., 2009; Brutinel et al., 2010). Since the 
amino-terminal domain of ExsA mediates self-association and is 
sufficient for complex formation with ExsD, ExsD likely inhibits 
ExsA self-association through steric hindrance. Less clear is how 
ExsD inhibits the carboxy-terminal DNA-binding domain when 
bound to the amino-terminus of ExsA. Resolution of this question 
will require structural studies to determine whether bound ExsD 
elicits a conformational change to the DNA-binding domain of 
ExsA or physically occludes one or both of the helix-turn-helix 
DNA-binding domains.
PhySIOLOGICAL ImPLICATIONS OF ThE ExsADCE REGULATORy 
CASCADE
The  T3SS  functions  as  a  primary  defense  mechanism  against 
phagocytosis  and  must  be  rapidly  activated  following  contact 
with a phagocyte. Prior to host cell contact, P. aeruginosa cells 
already express low levels of preexisting injectisomes (Rietsch and 
Mekalanos, 2006) and effectors that initiate the defense response. 
The ExsADCE regulatory cascade functions to increase the magni-
tude of the response by rapidly inducing expression of the injecti-
some components and effectors. While upregulation of T3SS gene 
expression would be important at the level of individual cells, in 
the context of an infection this requirement may not extend to the 
population as a whole. Single cell expression studies have dem-
onstrated that T3SS gene expression exhibits bistability whereby 
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represent  one  mechanism  for  activation  of  the AlgU  regulon, 
mucoid conversion in CF isolates usually results from nonsense 
mutations in mucA (Boucher et al., 1997; Mathee et al., 1997). 
Jin and colleagues were the first to observe that mucA mutants 
are defective for T3SS gene expression and found the inhibition 
to be mediated through the AlgZR two-component system (Wu 
et al., 2004). Wolfgang and colleagues later noted that vfr and mucA 
mutants  share  several  common  phenotypes  including  reduced 
expression of the T3SS, T2SS, exotoxin A, and type IV pili, and 
subsequently confirmed that mucA mutants are defective for vfr 
transcription (Figure 2; Jones et al., 2010). The lack of T3SS gene 
expression in mucA mutants, therefore, reflects a defect in cAMP/
Vfr signaling. Coincident mucoid conversion and loss of cAMP/
Vfr signaling suggests that the selective advantage of mucA mutants 
in the CF airways may extend beyond mucoidy itself (Rau et al., 
2010). Finally, the observation that algZR mutants have increased 
T3SS gene expression suggests that AlgZR modulates expression 
of the T3SS even in the presence of functional MucA (Jones et al., 
2010). Since the MucA/AlgU system controls a generalized stress 
response, an interesting question for the future is whether stress 
signals encountered within the host modulate T3SS gene expression 
through MucA/AlgU.
T3SS GENE EXPRESSION AND bIOFILm FORmATION
Like alginate production, P. aeruginosa biofilms are thought to con-
tribute to the chronic nature of CF infections (Singh et al., 2000). 
Biofilm formation is a complex adaptation subject to multiple layers 
of regulation (Harmsen et al., 2010). One regulatory mechanism 
involves the RetS and LadS sensor kinases. Whereas a retS   (regulator 
INvERSE REGULATION OF mUCOIDy AND T3SS GENE EXPRESSION
The role of the P. aeruginosa T3SS is well established within the con-
text of acute infections where it contributes to tissue damage, sepsis, 
and mortality (Engel and Balachandran, 2009). P. aeruginosa is also 
the most common cause of chronic airway infection in individuals 
with cystic fibrosis (CF). CF infections are characterized by biofilm 
growth, slow progression, minimal tissue damage, and restriction 
to the airways (Gomez and Prince, 2007). The mechanistic basis 
for the striking difference in the progression of acute (non-CF) and 
chronic CF infections is not well understood. One contributing 
factor is that many P. aeruginosa virulence determinants are dif-
ferentially expressed during non-CF and CF infections. Although 
CF and non-CF patients are initially colonized with nearly identi-
cal strains of P. aeruginosa, the majority of chronic CF isolates are 
mucoid and lack T3SS gene expression (Alonso et al., 1999; Feltman 
et al., 2001; Allmond et al., 2004). Mucoid conversion results from 
overproduction of the alginate polysaccharide and is associated 
with a decline in lung function and clinical prognosis (Pedersen 
et al., 1992; Li et al., 2005). Mucoid conversion and the loss of T3SS 
gene expression are now known to be linked events involving mucA 
mutation (Wu et al., 2004; Jones et al., 2010).
Alginate  biosynthesis  is  regulated  by  the  AlgU  alternative 
sigma factor and the membrane-bound MucA anti-sigma factor 
(Wozniak and Ohman, 1994; Govan and Deretic, 1996). MucA 
normally sequesters AlgU to prevent expression of the AlgU regulon 
(Figure 2; Schurr et al., 1996; Mathee et al., 1997). MucA is (indi-
rectly) responsive to a variety of environmental signals (primarily 
stress signals) resulting in the release of AlgU (Wood and Ohman, 
2009). Liberated AlgU activates many genes including the AlgZR 
two-component regulatory system and the alginate   biosynthetic 
FIguRE 2 | Working model for inverse regulation of T3SS with mucoidy and biofilm formation. See text for details.
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expression. Whereas a fliC mutant is deregulated for T3SS gene 
expression (three- to ninefold) and displays increased cytotoxic-
ity toward a macrophage cell line, ExsA over-expression reduces 
motility and expression of a fliA transcriptional reporter (Soscia 
et al., 2007). The reciprocal nature of T3SS and flagellar gene 
expression is interesting to contemplate in the context of inflam-
masome activation. Several studies suggest that flagellin (FliC) 
translocated into macrophages by the P. aeruginosa T3SS acti-
vates the inflammasome leading to a proinflammatory response 
(Franchi et al., 2007; Galle et al., 2007; Sutterwala et al., 2007; Miao 
et al., 2008). Despite experimental evidence of inflammasome 
activation ex vivo, it is unclear whether this occurs in vivo because 
the ExoS and ExoU effectors both block FliC-dependent inflam-
masome activation. The additional finding that FliC expression 
is inversely regulated with T3SS gene expression suggests that 
inflammasome activation is either relatively unimportant, does 
not normally occur during infections, or occurs under conditions 
that remain to be defined.
ENvIRONmENTAL SIGNALS ThAT mODULATE T3SS GENE EXPRESSION
Ca2+-limitation and host cell contact are well-defined signals that 
activate transcription through the control of T3SS secretory activ-
ity. Many additional signals, arising from both endogenous and 
exogenous sources, also influence T3SS gene expression and are 
summarized in Table 1. Evident is the fact that these signals are 
diverse with stress and metabolic signals representing the largest 
class. Less obvious is that the mechanisms by which these signals 
influence T3SS gene expression are poorly understood. In fact, 
besides ExsA only one additional transcriptional factor (PsrA) 
is known to directly regulate the T3SS. PsrA binds the PexsC pro-
moter to positively control transcription of the exsCEBA operon 
(Shen et al., 2006). Interestingly, the DNA-binding activity of PsrA 
is directly inhibited by long chain fatty acids. Indeed T3SS gene 
expression is reduced in the presence of long chain fatty acids, 
although the biological significance of this observation is unclear 
(Kang et al., 2009). The involvement of PsrA is discussed here to 
illustrate the point that cross-talk between different regulatory 
systems coordinates T3SS gene expression with diverse cellular 
functions. In addition to the T3SS, PsrA regulates a diverse set 
of genes including type IV pili (a potential link to Vfr), the psl 
biosynthesis operon (a potential link to RsmA), the stationary 
phase sigma factor rpoS (a potential link to quorum sensing) and 
a variety of genes involved in metabolic and energetic metabo-
lism.  Furthermore,  psrA  mutants  are  defective  for  swarming 
motility, biofilm formation, and resistance to some antibiotics. 
In just this one example, therefore, one begins to appreciate the 
level of complexity involved in controlling T3SS gene expression. 
Despite the involvement of numerous signals and gene products, 
it seems likely that reductionist approaches will ultimately reveal 
that only a minority (i.e., PsrA, Vfr, RsmA) of the genes implicated 
in regulation of the T3SS directly participate in the control of 
T3SS gene expression. Future explorations aimed as examining 
whether signals and gene products exert their regulatory effects at 
the level of ExsADCE or through upstream regulatory pathways 
are required to fully integrate the regulatory pathways leading to 
T3SS gene expression.
of exopolysaccharide and type III secretion) mutant is defective 
for T3SS gene expression and displays enhanced biofilm forma-
tion, a ladS mutant has the reciprocal phenotypes (Goodman et al., 
2004; Ventre et al., 2006). Mechanistically, RetS and LadS medi-
ate opposite effects on activation of the GacAS system (Figure 2). 
The GacAS system regulates biofilm formation through control 
of the Pel and Psl polysaccharides, key components of the biofilm 
matrix (Ryder et al., 2007). Psl biosynthesis is controlled at the 
post-transcriptional level by RsmA, an RNA-binding protein that 
binds directly to the 5′ UTR region of the pslA mRNA to inhibit 
translational initiation (Irie et al., 2010). In response to unknown 
signals, GacA activates transcription of two small non-coding regu-
latory RNAs (RsmY and RsmZ). RsmY and RsmZ each have ∼4–6 
binding sites for RsmA and function by sequestering free RsmA 
from target mRNAs (Lapouge et al., 2008). Decreased levels of 
free RsmA, therefore, are required for Psl expression. In contrast, 
T3SS gene expression is dependent upon increased levels of free 
RsmA (Goodman et al., 2004; Mulcahy et al., 2006). The mecha-
nism by which RsmA promotes T3SS gene expression is poorly 
understood. RsmA is a member of the CsrA family of proteins 
first described in E. coli (Romeo et al., 1993). Although CsrA fam-
ily members usually prevent translation by binding to or near the 
Shine–Dalgarno (SD) sequence of target mRNAs (Lapouge et al., 
2008), direct positive regulation by CsrA has also been reported 
and involves mRNA stabilization (Wei et al., 2001). This leaves 
several scenarios to account for positive regulation of T3SS gene 
expression by RsmA. RsmA may function directly at the level of 
intrinsic regulation by promoting expression of a positive (ExsA 
or ExsC) acting factor or inhibiting expression of negative (ExsD 
or ExsE) regulator. Alternatively, RsmA may function indirectly by 
modulating an extrinsic regulatory pathway that controls the T3SS. 
With respect to the latter possibility it is noteworthy that the RsmA 
regulon is extensive and includes rhamnolipid production, lipase 
production, swarming motility, quorum sensing, lectin, pyocyanin, 
hydrogen cyanide, and the type VI secretion system (Pessi et al., 
2001; Heurlier et al., 2004; Brencic and Lory, 2009). The possibil-
ity exists, therefore, that the regulatory activity of RsmA toward 
T3SS gene expression results from pleiotropic effects that may be 
difficult to define.
The observation of inverse regulation by RetS and LadS implied 
that T3SS gene expression and biofilm formation were mutually 
exclusive events. It is now becoming apparent, however, that such a 
model is an over-simplification and that the T3SS is possible during 
biofilm growth (Mikkelsen et al., 2009).
T3SS GENE EXPRESSION AND mOTILITy
All  three  forms  of  P.  aeruginosa  motility  (type  IV  pili-based 
twitching, swarming, and flagellar-based swimming,) are coor-
dinated (either positively or negatively) with T3SS gene expres-
sion. As described above, type IV pili and T3SS gene expression 
are positively regulated by Vfr (Jones et al., 2010). The biological 
significance of this relationship reflects the adherence properties 
provided by type IV pili, which function as the primary adhesin 
for host-contact-dependent expression of the T3SS (Sundin et al., 
2002). T3SS gene expression is also positively correlated with 
swarming motility, which might be advantageous during colo-
nization of mucosal surfaces (Overhage et al., 2008). In contrast, 
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in that regulatory phenotypes that alter T3SS gene expression might 
result from pleiotropic effects without actually contributing to the 
regulatory process per se.
Therapeutic targeting of the T3SS is an achievable goal with poten-
tial intervention points including the inhibition of assembly, secre-
tion, translocation, and T3SS gene expression. Since ExsA-dependent 
transcription is dependent upon an intact secretion and translocation 
machinery, each class of inhibitor offers the added benefit of reduced 
T3SS gene expression. Most efforts to date have logically targeted 
the highly conserved secretion/translocation machinery with the 
hope of identifying inhibitors that possess activity against multiple 
pathogens. A limitation of this approach lies in identification of the 
inhibitor target since each of the ∼25 constituents of the secretion/
translocation machinery as well as their interaction interfaces rep-
resent potential target sites. Direct targeting of transcription offers 
the advantage that many promising targets already exist including 
the ExsADCE regulatory cascade, and the cAMP/Vfr, MucA/AlgU, 
and GacA/RsmA global regulatory pathways, and in fact inhibitors 
of ExsA-dependent transcription have already been identified (Grier 
et al., 2010). Time will tell whether such inhibitors can deliver on the 
promise of controlling P. aeruginosa infections.
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ChALLENGES FOR ThE FUTURE
The literature contains a wealth of information regarding genes and 
conditions that contribute to T3SS gene expression in P. aeruginosa. 
The challenge ahead lies in assimilating this information into a uni-
fied regulatory network supportive of all prior and future observa-
tions. In absolute terms this will undoubtedly prove impossible owing 
to differences in mutant phenotypes, strain backgrounds, growth 
conditions, and experimental findings. In analyzing the primary lit-
erature consideration of the following points is important to keep 
in mind: (i) Nearly 20 microarray studies have noted alterations in 
T3SS gene expression. Most of these studies were conducted under 
non-permissive conditions for T3SS gene expression (i.e., high Ca2+) 
making it difficult to ascertain whether the observed changes rep-
resent minor alterations to the basal level of T3SS transcription or 
more significant regulatory effects. (ii) To the best of our knowledge, 
plasmid-expressed ExsA is able to restore transcription to all mutants 
identified as defective for T3SS transcription. Reports of regulatory 
effects occurring upstream of ExsA, therefore, must be interpreted 
with caution since ExsA over-expression can easily obscure the activ-
ity of and/or requirement for other regulatory systems. (iii) Although 
most studies of T3SS gene expression have relied upon Ca2+ chelation 
as the inducing signal, it is unlikely that Ca2+ chelation and host cell 
contact are entirely analogous signals. Future studies are required to 
fully define the physiologically relevant signals encountered in vivo 
and determine how they modulate or fine-tune T3SS gene expression. 
(iv) The induction of T3SS gene expression is minimally dependent 
upon a functional injectisome, the ExsADCE cascade, and the Vfr and 
Table 1 | Environmental signals that influence T3SS gene expression.
Signal  Effect on T3SS  Implicated genes  Reference
AcTIVATIoN oF SEcRETIoN
Host cell contact  +  exsADCE  Vallis et al. (1999), Urbanowski et al. (2007)
Low calcium  +  exsADCE  Frank (1997)
Serum/albumin  +  exsADCE  Vallis et al. (1999), Kim et al. (2005)
ENVIRoNMENTAl STRESS
DNA damage  −  recA, ptrB, prtN, prtR  Wu and Jin (2005)
Hyperosmotic stress  +  cAMP/Vfr  Aspedon et al. (2006), Rietsch and Mekalanos (2006)
Copper stress  −  ptrA  Ha et al. (2004)
METAbolIc SIgNAlS/STRESSES
Pyruvate imbalance  −  aceA, aceB  Dacheux et al. (2002)
Unknown  −  gltR, gltA cbrA  Rietsch et al. (2004), Rietsch and Mekalanos (2006)
Spermidine/spermine  +  spuE  Zhou et al. (2007)
Tryptophan metabolites  −  trpA, leuC  Shen et al. (2008)
Long chain fatty acids  −  psrA, rpoS  Kang et al. (2009)
Mucin  ±  unknown  Tralau et al. (2007)
PQS  −  pqsR, mvfR  Singh et al. (2010)
ANAERobIoSIS
NO  +  nirS, narGH  Van Alst et al. (2009)
ANTIbIoTIc ExPoSuRE
Azithromycin  +  mexCD-oprJ, ptrA  Gillis et al. (2005)
Chloramphenicol  −  mexEF  Linares et al. (2005)
Tetracycline  +  unknown  Linares et al. (2006)
Antimicrobial peptides  −  psrA  Gooderham et al. (2008)
Quorum sensing  −  rpoS  Hogardt et al. (2004), Bleves et al. (2005)
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